CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 40 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,000 | -33.3% | 481 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 481 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 481 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 481 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -40.0% | 481 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | +25.0% | 481 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | 0.0% | 481 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | 0.0% | 481 | 0.0% | 0.00% | – |
Q4 2017 | $4,000 | +33.3% | 481 | 0.0% | 0.00% | – |
Q3 2017 | $3,000 | -75.0% | 481 | -75.0% | 0.00% | – |
Q2 2017 | $12,000 | +20.0% | 1,922 | 0.0% | 0.00% | – |
Q1 2017 | $10,000 | -23.1% | 1,922 | 0.0% | 0.00% | – |
Q4 2016 | $13,000 | -7.1% | 1,922 | 0.0% | 0.00% | – |
Q3 2016 | $14,000 | -12.5% | 1,922 | 0.0% | 0.00% | – |
Q2 2016 | $16,000 | +100.0% | 1,922 | +33.3% | 0.00% | – |
Q1 2016 | $8,000 | 0.0% | 1,442 | 0.0% | 0.00% | – |
Q4 2015 | $8,000 | +33.3% | 1,442 | 0.0% | 0.00% | – |
Q3 2015 | $6,000 | -14.3% | 1,442 | 0.0% | 0.00% | – |
Q2 2015 | $7,000 | +16.7% | 1,442 | 0.0% | 0.00% | – |
Q1 2015 | $6,000 | – | 1,442 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Penbrook Management LLC | 354,670 | $887,000 | 0.55% |
Newbridge Financial Services Group, Inc. | 61,675 | $154,000 | 0.10% |
GAGNON SECURITIES LLC | 47,793 | $119,000 | 0.02% |
Phocas Financial Corp. | 30,000 | $75,000 | 0.01% |
ROYCE & ASSOCIATES LP | 491,453 | $1,229,000 | 0.01% |
SEGALL BRYANT & HAMILL, LLC | 701,318 | $1,754,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 179,680 | $449,000 | 0.01% |
Jump Financial, LLC | 37,900 | $95,000 | 0.01% |
Cutler Group LLC / CA | 44,918 | $112,000 | 0.01% |
Virtu Financial LLC | 19,653 | $49,000 | 0.00% |